Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:344-347

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagueh, S. F.
Right arrow Articles by Spencer, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagueh, S. F.
Right arrow Articles by Spencer, W. H.
Related Collections
Right arrow Myocardial cardiomyopathy disease
Right arrow Echocardiography

(Circulation. 1999;99:344-347.)
© 1999 American Heart Association, Inc.


Brief Rapid Communications

Changes in Left Ventricular Diastolic Function 6 Months After Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy

Sherif F. Nagueh, MD; Nasser M. Lakkis, MD; Katherine J. Middleton, RCT; Donna Killip, RN; William A. Zoghbi, MD; Miguel A. Quiñones, MD; William H. Spencer, III, MD

From the Department of Medicine, Cardiology Section, Baylor College of Medicine, Houston, Tex.

Correspondence to Sherif F. Nagueh, MD, Cardiology Section, Baylor College of Medicine, 6550 Fannin, SM1246, Houston, TX 77030. E-mail sherifn{at}bcm.tmc.edu

Abstract

Background—Nonsurgical septal reduction therapy (NSRT) decreases left ventricular outflow tract (LVOT) gradient and improves symptoms in patients with hypertrophic obstructive cardiomyopathy (HOCM). NSRT effects on LV/left ventricular diastolic function are currently unknown.

Methods and Results—HOCM patients (n=29) had Doppler echocardiography at baseline and 6 months after NSRT to evaluate changes in LV volume, pre–A-wave pressure, early diastolic mitral annulus velocity (Ea) by tissue Doppler, and {tau}. At 6 months, a significant reduction in LVOT gradient (from 53.6±15 to 6±5 mm Hg; P<0.001) was accompanied by improvement in exercise duration (from 284±147 to 408±178 seconds; P=0.04) and New York Health Association class (from III to I; P<0.001). Pre-A pressure (18±6 to 14±5 mm Hg; P<0.01) and {tau} (62±8 to 51±8 ms; P<0.01) decreased, whereas Ea (5.8±1.8 to 8±1.8 cml/s; P<0.01) and LV end-diastolic volume (117±16 to 130±22 mL; P<0.01) increased.

Conclusions—NSRT improves LV relaxation and compliance, which contributes to the symptomatic relief seen at 6 months.


Key Words: diastole • cardiomyopathy • hypertrophy • echocardiography




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. Wang, J. M. Buergler, K. Veerasamy, Y. P. Ashton, and S. F. Nagueh
Delayed untwisting: the mechanistic link between dynamic obstruction and exercise tolerance in patients with hypertrophic obstructive cardiomyopathy.
J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1326 - 1334.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
P. Sorajja, R. A. Nishimura, S. R. Ommen, C. S. Rihal, B. J. Gersh, and D. R. Holmes Jr
Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy: An Invasive Hemodynamic Study
J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 552 - 560.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. A. Fifer and G. J. Vlahakes
Management of Symptoms in Hypertrophic Cardiomyopathy
Circulation, January 22, 2008; 117(3): 429 - 439.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Shingu, N. Shiiya, T. Mikami, K. Matsuzaki, T. Kunihara, and Y. Matsui
Left Ventricular Diastolic Dysfunction in Chronic Aortic Dissection
Ann. Thorac. Surg., April 1, 2007; 83(4): 1356 - 1360.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. S. Jassal, T. G. Neilan, M. A. Fifer, I. F. Palacios, P. A. Lowry, G. J. Vlahakes, M. H. Picard, and D. M. Yoerger
Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
Eur. Heart J., August 1, 2006; 27(15): 1805 - 1810.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H. Dokainish and N. Lakkis
Alcohol relaxes the stiff heart
Eur. Heart J., August 1, 2006; 27(15): 1769 - 1770.
[Full Text] [PDF]


Home page
CirculationHome page
W. G. van Dockum, A. M. Beek, F. J. ten Cate, J. M. ten Berg, O. Bondarenko, M. J.W. Gotte, J. W.R. Twisk, M. B.M. Hofman, C. A. Visser, and A. C. van Rossum
Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
Circulation, May 17, 2005; 111(19): 2503 - 2508.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
B. W.L. De Boeck, J. K. Oh, P. M. Vandervoort, J. A. Vierendeels, R. P.L.M. van der Aa, and M.-J. M. Cramer
Colour M-mode velocity propagation: a glance at intra-ventricular pressure gradients and early diastolic ventricular performance
Eur J Heart Fail, January 1, 2005; 7(1): 19 - 28.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. S. Bradham Jr, H. Gunasinghe, J. R. Holder, M. Multani, D. Killip, M. Anderson, D. Meyer, W. H. Spencer III, G. Torre-Amione, and F. G. Spinale
Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy
J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2165 - 2173.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T.-H. Park, N. M. Lakkis, K. J. Middleton, J. Franklin, W. A. Zoghbi, M. A. Quinones, W. H. Spencer III, and S. F. Nagueh
Acute Effect of Nonsurgical Septal Reduction Therapy on Regional Left Ventricular Asynchrony in Patients With Hypertrophic Obstructive Cardiomyopathy
Circulation, July 23, 2002; 106(4): 412 - 415.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. F. Nagueh, S. R. Ommen, N. M. Lakkis, D. Killip, W. A. Zoghbi, H. V. Schaff, G. K. Danielson, M. A. Quinones, A. J. Tajik, and W. H. Spencer III
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1701 - 1706.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. F. Nagueh, S. J. Stetson, N. M. Lakkis, D. Killip, A. Perez-Verdia, M. L. Entman, W. H. Spencer III, and G. Torre-Amione
Decreased Expression of Tumor Necrosis Factor-{{alpha}} and Regression of Hypertrophy After Nonsurgical Septal Reduction Therapy for Patients With Hypertrophic Obstructive Cardiomyopathy
Circulation, April 10, 2001; 103(14): 1844 - 1850.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. F. Nagueh, N. M. Lakkis, K. J. Middleton, D. Killip, W. A. Zoghbi, M. A. Quinones, and W. H. Spencer III
Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1123 - 1128.
[Abstract] [Full Text] [PDF]